Skip to content

Homeopathic medicine for patients with ringworm of the body.

Efficacy of individualized homoeopathic medicines in the treatment of tinea corporis in adults: A double-blind, randomized, placebo-controlled trial. - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093480
Enrollment
108
Registered
2025-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Individualized homoeopathic medicines plus Concomitant care: The planned intervention involves administering indicated homeopathic medicines in centesimal potencies (CH). Each dose con
dosage and repetition will depend on the individuals requirements in each case. Patients will be instructed to avoid handling the globules and to refrain from eating, drinking, smoking, or brushing t

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from tinea corporis (1F21.1 ref. ICD11) for 3 months or more, diagnosis confirmed through KOH mount test. 2.Age between 18 and 65 years 3.Patients of either sex or transgender. 4.Patients previously treated with topical antifungal agents will be eligible for enrolment following a minimum washout period of seven days.

Exclusion criteria

Exclusion criteria: 1.Patients with complications such as lichenification or eczematization. 2.Skin conditions that mimic tinea, such as seborrheic dermatitis, pityriasis rosea, and psoriasis. 3.Individuals who are too unwell for consultation, unable to comprehend the patient information sheet, or unwilling to participate. 4.Diagnosed cases of other systemic disease i.e., uncontrolled diabetes or life-threatening illness affecting quality of life, or any organ failure. 5.Vulnerable groups include unconscious, non-ambulatory, critically or terminally ill patients, differently abled individuals, and those with mental incompetence. 6.Pregnant, postpartum, or lactating women. 7.Individuals with a history of tobacco use (chewing or smoking), alcohol dependency, or any form of substance abuse (TAPS tool) [36]. 8.Self-reported immunocompromised individuals, AIDS, hepatitis, etc. 9.Patients who have received homeopathic treatment for a chronic illness within the last six months. 10.Simultaneous participation in any other clinical activity.

Design outcomes

Primary

MeasureTime frame
Skindex-29 questionnaireTimepoint: At baseline, monthly, up to 2 months

Secondary

MeasureTime frame
5- D Pruritus ScaleTimepoint: At baseline, monthly, up to 2 months;Measure Yourself Medical Outcome Profile version 2.0 (MYMOP-2)Timepoint: At baseline, monthly, up to 2 months

Countries

India

Contacts

Public ContactRajat Kumar Pal

D N De Homoeopathic Medical College and Hospital

nafisakhatun062@gmail.com8617300530

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026